Clinical Trial Update: A Study of Once Monthly Subcutaneous Mircera in Patients With Chronic Renal Anemia Not on Dialysis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating once-monthly subcutaneous Mircera for anemia in chronic kidney disease patients not on dialysis completed with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• MIRCERA (METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Anemia | Phase 4 | Status: COMPLETED | Results posted: 2015-12-09